Vogl,NY on How to Ask Good Questions at Medical Meetings

Vogl, NY

S. Vogl

Hyperprogression in Cancer Treated With Immunotherapy

Northwestern Medicine Oncology and Hematology

Y. Chae

Updates in Combination Therapy for HCC

Yale Cancer Center

S. Stein

ESMO 2024 Summary: Highlights in HCC

2024 ESMO Annual Meeting Insights Hub

R. Kim, T. Biachi

ASCO® 2024 Summary: "Experts Discuss Key Studies in HCC and BTC"

2024 ASCO® Annual Meeting Insights Hub

R. Kim, T. Biachi

ESMO 2024 Insights: TACE ± Lenvatinib + Pembro for Int-Stage HCC - P…

2024 ESMO Annual Meeting Insights Hub

J. Llovet

2023 AASLD Guidance for HCC

University of Texas Southwestern Medical Center

A. Singal

Year in Review: Hepatobiliary Cancers

Moffitt Cancer Center

R. Kim, T. Biachi

ASCO® GI 2024 Summary: "HCC Key Studies Including EMERALD-1 & IMbrav…

Insights from 2024 ASCO® GI Annual Meeting

R. Kim, T. Biachi

Understanding HCC: Perspectives on Diagnosis, Risk Factors, and Trea…

Yale Cancer Center

A. Jaffe

ESMO 2024 Summary: Updates in HCC and Impacts on Practice

2024 ESMO Annual Meeting Insights Hub

H. Babiker

Hepatocellular Carcinoma: Current Management Strategies

Stanford Medicine

R. Dhanasekaran

ACG 2023 Highlights: HCC Updates - Diagnosis and Management

ACG 2023 Conference Coverage

R. Wong

Expert Panel on TACE and TARE for HCC: Weighing the Pros and Cons

Integrity CE

M. Pishvaian, R. Salem

HCC: Updates in Management

Stanford Medicine

R. Dhanasekaran

GI Oncology Year in Review: Hepatobiliary Cancers

Yale Cancer Center

P. Kunz

SIR 2023: Histotripsy - Technology and Clinical Evidence

SIR 2023 Conference Coverage

T. Ziemlewicz

Hepatic Hilar Nerve Block for Adjunctive Analgesia during Percutaneo…

Dennis Parhar

MRD in GI Malignancies: Current Clinical Utility of ctDNA

Horizon CME

A. Scott

The Role of Adjuvant Therapy Following HCC Resection

Integrity CE

M. Baretti